DraftKings Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.2% | -3.7% | +11.0% | +1.3% | +0.3% | +5.4% | -0.9% | +3.4% | -2.0% | -4.9% | -0.7% | |
| – | +5.3% | -6.4% | -21.4% | +7.9% | -6.7% | +17.4% | -0.8% | +8.9% | -6.7% | -13.1% | 0.0% | |
| – | +14.3% | -6.1% | -31.6% | +7.6% | -10.2% | +42.0% | +12.7% | -2.7% | +30.6% | -37.7% | -1.6% | |
| – | +14.3% | -6.1% | -31.6% | +7.6% | -10.2% | +42.0% | +12.7% | -2.7% | +30.6% | -37.7% | -1.6% | |
| – | +47.2% | -8.6% | -5.3% | +34.3% | -70.4% | +22.6% | -7.4% | -52.0% | +61.1% | -18.4% | -4.7% | |
| – | – | – | +0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +64.3% | +0.0% | +6.8% | +0.0% | +0.0% | +0.0% | +2.7% | +0.0% | +0.0% | |
| – | -3.9% | -1.2% | +39.1% | -6.1% | +4.6% | -3.1% | -2.7% | -2.2% | +3.3% | -2.4% | -3.5% | |
| – | +1.5% | -4.3% | -1.7% | +9.5% | +2.4% | +11.3% | -4.9% | +12.3% | +0.2% | -5.0% | +0.1% | |
| – | +1.4% | -7.0% | -4.7% | +19.9% | +0.5% | -9.4% | -11.0% | +33.1% | -1.2% | -11.8% | +0.1% | |
| – | -5.2% | -2.0% | +1.8% | -1.8% | -2.5% | +0.8% | +2.5% | +0.9% | -14.6% | +11.7% | -11.0% | |
| – | -90.4% | +1,675.4% | -5.3% | +22.2% | -92.3% | +975.4% | -4.1% | +28.6% | +10.4% | -10.4% | -2.1% | |
| – | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +46.7% | -0.3% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | +4.9% | -1.1% | +56.3% | -17.1% | -6.1% | -13.6% | +15.7% | -27.5% | -13.8% | -4.2% | -5.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.7% | +1.3% | +1.1% | +1.4% | +0.4% | +1.1% | +7.3% | +0.0% | +0.5% | +0.0% | -6.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.